PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $2.53M invested in PAVmed Inc. Series Z Warrant in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
223% more capital invested
Capital invested by funds: $784K → $2.53M (+$1.75M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$558K |
| 2 |
MRCM
M&R Capital Management
Summit,
New Jersey
|
+$41.4K |
| 3 |
LCS
Levin Capital Strategies
New York
|
+$21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$90.3K |
| 2 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $1.46M | +$558K | +1,124,541 | New |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $915K | -$90.3K | -181,862 | -9% |
|
|
LCS
3
Levin Capital Strategies
New York
| $94K | +$21K | +42,380 | +27% |
|
|
MRCM
4
M&R Capital Management
Summit,
New Jersey
| $39K | +$41.4K | +83,335 | New |
|
|
LWAC
5
Laurel Wealth Advisors (California)
Solana Beach,
California
| $21K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $2K | -$2.72K | -5,478 | -55% |
|
|
7
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$8K | -22,574 | Closed |
|
PAVMZ Hedge Fund Activity: Q3 2018 in Review
6 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q3 2018, worth a combined $2.53M — up 223% from $784K a quarter earlier.
Fund positioning in PAVMZ was balanced in Q3 2018: 2 funds opened new positions, 2 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $558K. The largest seller was Sabby Management, cutting an estimated $90.3K.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $2.53M of PAVmed Inc. Series Z Warrant stock for Q3 2018, up 223% quarter-over-quarter.
- 2 funds opened new PAVmed Inc. Series Z Warrant positions in Q3 2018 and 2 closed out, a net change of 0 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q3 2018 was Anson Funds Management, an estimated $558K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q3 2018 was Sabby Management, an estimated $90.3K sold.
Based on aggregated 13F filings for Q3 2018.